Back to Search
Start Over
Secukinumab demonstrates significantly lower immunogenicity potential compared with ixekizumab and adalimumab
- Source :
- Journal of the American Academy of Dermatology. 79:AB256
- Publication Year :
- 2018
- Publisher :
- Elsevier BV, 2018.
Details
- ISSN :
- 01909622
- Volume :
- 79
- Database :
- OpenAIRE
- Journal :
- Journal of the American Academy of Dermatology
- Accession number :
- edsair.doi...........1ee1746d1e2802606621cb4c2c7c5f11
- Full Text :
- https://doi.org/10.1016/j.jaad.2018.05.1017